Who we are
Creating a future worth living. For patients. Worldwide. Every day.
Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which approximately 4.1 million patients worldwide regularly undergo dialysis treatment. United by a shared purpose of creating a future worth living for chronically and critically ill people, we care for more than 332,000 dialysis patients around the globe. Their well-being always comes first.
It is our mission to provide the best possible care for a growing number of patients sustainably in diverse health care systems. As a vertically integrated company, our portfolio encompasses a comprehensive range of high-quality health care products and services as well as various dialysis treatment options for both in-center and home dialysis.
Shaping the future of kidney care
2023 was a year full of fundamental transformation that we successfully mastered as a company. We are proud of our achievements and have laid the foundation for sustainable profitable growth, and to continue meeting our high standards in shaping the future of kidney care for the benefit of our patients.
Revenue
Solid organic growth
Operating income
Exceeding top end of outlook range
Net Income
Growth driven by favorable business development
Dividend per share
Download - Annual Report
Download our Annual Report and get detailed information about our fiscal year 2023.
Download – Non-financial Group Report
Download our Non-financial Group report and get an overview of our sustainability efforts in the 2023 fiscal year.
